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Abstract Acidic pH-induced folding of annexin (Anx)VI in
solution was investigated in order to study the mechanism of
formation of ion channels by the protein in membranes. Using 2-
(p-toluidino)naphthalene-6-sulfonic acid as a hydrophobic probe,
it was demonstrated that AnxVI exerts a large change in
hydrophobicity at acidic pH. Moreover, circular dichroism
spectra indicated that the native state of AnxVI changes at
acidic pH towards a state characterized by a significant loss of
K-helix content and appearance of new L-structures. These
changes are reversible upon an increase of pH. It is postulated
that the structural folding of AnxVI could explain how a soluble
protein may undergo transition into a molecule able to penetrate
the membrane hydrophobic region. The physiological signifi-
cance of these observations is discussed. ß 2001 Published by
Elsevier Science B.V. on behalf of the Federation of European
Biochemical Societies.
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1. Introduction
Annexin (Anx)VI [1,2], a member of a family of homolo-
gous Ca2- and phospholipid-binding proteins is expressed in
two isoforms in mammalian tissues. Both isoforms interact
with membranes enriched with phosphatidylserine (PtdSer)
at neutral pH in a Ca2-dependent manner [3]. The larger
isoform of AnxVI contains 673 amino acids with a Mr of
68 kDa and pI of 5.8 [4,5]. The crystal structures of AnxVI
in soluble (human) [6] and membrane-bound (bovine) [7] form
have been solved, indicating that Ca2 does not produce a
major conformational change in AnxVI under physiological
pH and ionic strength. Recently, it was found that porcine
liver AnxVI, which is similar to its human counterpart [8], is
able to bind to phospholipid bi- and monolayers in a Ca2-
independent manner, stimulated by acidic pH (half-maximal
binding to asolectin liposomes occurred at pH 5.3) [9]. The
binding was accompanied by the formation of voltage-depen-
dent non-speci¢c ion channels by AnxVI with a single channel
conductance of 24 pS under symmetric conditions (50 mM
CsCl), as determined by the black lipid membrane technique
[9]. As a mechanism of channel formation, it has been pro-
posed that AnxVI undergoes profound changes of its native
structure that are accompanied by an increase in the overall
hydrophobicity of the protein [9].
In the present report we have tested this hypothesis by
using £uorescence and far-UV circular dichroism (CD) mea-
surements. With this experimental approach we observed a
profound increase of protein hydrophobicity at acidic pH
and the appearance of an AnxVI conformational state that
varies from the native AnxVI structure near pH 7.0. Such
behavior may explain the existence of Ca2-independent iso-
forms of AnxVI that were observed by other investigators
within the cells to behave as membrane integral proteins
[10^13].
2. Materials and methods
2.1. Chemicals
PtdSer, N-acetyl-L-tryptophan amide and 2-(p-toluidino)naphtha-
lene-6-sulfonic acid (TNS) were purchased from Sigma-Aldrich
(Poznan, Poland). All other chemicals were of the highest purity com-
mercially available.
2.2. Preparation of porcine liver AnxVI
The fraction of Ca2-binding proteins enriched in AnxVI was iso-
lated from porcine liver homogenate by means of Ca2 precipitation.
Further puri¢cation of AnxVI to homogeneity was achieved using ion
exchange chromatography, as previously described [8,14]. The protein
was lyophilized and stored at 320‡C until use. Protein purity was
veri¢ed by sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) and monoclonal antibodies against human AnxVI (Sig-
nal Transduction Laboratories, Lexington, KY, USA) that recognized
the porcine liver AnxVI isoform. In addition, some proteolytic frag-
ments of AnxVI were directly sequenced after electroblotting onto
polyvinylidene di£uoride membranes, con¢rming its identity [8].
2.3. Steady-state £uorescence measurements
All £uorescence and light scattering measurements described in this
report were performed with the aid of a Fluorolog 3 Spectrometer
(SPEX) at 25‡C in a quartz cuvette of 5 mm optical pathlength. The
following bu¡ers were used: 10 mM citric bu¡er in the pH range from
3.0 to 6.2, or 10 mM Tris^HCl bu¡er in the pH range from 7.0 to 8.3,
supplemented with 50 mM NaCl and 0.1 mM EGTA. These bu¡ers
are called citric or Tris^HCl throughout the text.
The £uorescence emission spectra of TNS in the presence or ab-
sence of AnxVI were recorded between 350 and 570 nm at 25‡C with
Vex = 345 nm [15]. For TNS alone, the Vmax of emission amounted to
490 nm. Both emission and excitation slits were set at 0.5 nm. TNS
concentrations varied from 0 to 30 WM at a ¢xed protein concentra-
tion (1 WM).
Fluorescence resonance energy transfer (FRET) was determined by
recording £uorescence emission spectra of AnxVI Trp residues (a
donor) in the presence of various concentrations of TNS (an acceptor)
from 0 to 30 WM. The pH of the assay medium varied from pH 3.0 to
8.3. Samples were excited at Vex = 295 nm, with emission and excita-
tion slits set at 1 nm. The donor and acceptor £uorescence emission
intensities were recorded in the wavelength range from 300 to 500 nm
at 1 nm intervals. The energy transfer e⁄ciency (E) was calculated on
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the basis of the following equation: E = 13(NDA/ND), where ND is the
£uorescence e⁄ciency of the donor and NDA is the £uorescence e⁄-
ciency of the donor in the presence of an acceptor [16].
To determine the intrinsic £uorescence of AnxVI as a function of
pH, the emission spectra of AnxVI (0.2 WM) were monitored at 25‡C
with a 2 nm spectral resolution for both excitation and emission, in
the wavelength range from 300 to 400 nm at a pH range from 3.0 to
8.3 (Vex = 295 nm). Under the same conditions, the emission spectra of
N-acetyl-L-tryptophan amide in a concentration range corresponding
to the concentration of AnxVI Trp residues were also recorded. They
revealed no pH-sensitivity, as already described in [17].
Light scattering of AnxVI in solution was measured in order to
determine protein aggregation. Scattered light at 90‡ was collected
between 360 and 400 nm (in 10 nm steps). The assay medium con-
tained 0.02 or 0.2 mg/ml of AnxVI in citric or Tris^HCl bu¡ers,
supplemented with NaCl and EGTA.
2.4. CD measurements
The far-UV CD spectra of AnxVI were collected at 25‡C using an
AVIV CD spectrophotometer (AVIV Associates, USA) in a 5 mm
optical pathlength quartz cuvette. The assay media contained citric
(pH 3.0^6.2) or Tris^HCl (pH 7.0^8.3) bu¡ers, 0.2 mg/ml of AnxVI,
50 mM NaCl and 0.1 mM EGTA. Each spectrum was recorded as an
average of six scans between 190 and 260 nm. Participation of K-helix
and L-sheet structures in protein secondary structure was calculated
with the aid of Contin software (1999 edition).
2.5. Other procedures
The protein concentration was determined according to the Brad-
ford method [18], with bovine serum albumin as a standard. SDS^
PAGE (reducing conditions) was performed on 6% stacking and 12%
resolving gels; gels were stained with Coomassie brilliant blue [19].
3. Results
Using TNS as a hydrophobic probe, it was determined that
the hydrophobicity of AnxVI increases upon acidi¢cation of
the assay medium. The binding of TNS to AnxVI is evidenced
by a signi¢cant enhancement of TNS £uorescence intensity
and a remarkable blue shift of its £uorescence emission Vmax
from 490 nm in the absence of protein to 427 nm in the
presence of AnxVI (Fig. 1A). These changes were markedly
dependent on pH, with a midpoint of the titration at pH 5.5.
It is worth stressing that the £uorescence of TNS alone was
independent of pH, in the pH range studied, as also reported
by Kachel et al. [20].
The binding of TNS was accompanied by FRET from ex-
cited Trp residues of AnxVI to TNS at low pH. FRET is
evidenced from the quenching of AnxVI £uorescence intensity
at pH 4.6 in the presence of increasing concentrations of TNS
(Fig. 1B). The results of the reciprocal experiment, i.e. deter-
mination of FRET at ¢xed concentrations of AnxVI and TNS
but various pH values (from pH 3.0 to 8.3) or titration of
TNS with various AnxVI concentrations, resulted in the same
conclusion that signi¢cant FRET occurs only at acidic pH,
while at pH 7.4 FRET was negligible (not shown). These
experiments revealed that FRET is the result of TNS^AnxVI
interactions but not changes in the £uorescence properties of
the protein. FRET e⁄ciency depended on pH and TNS con-
centration (Fig. 2), pointing to the existence of an AnxVI state
with higher protein hydrophobicity than the native state at
pH 7.4^8.0, with a low degree of hydrophobicity. If the
changes in AnxVI hydrophobicity at acidic pH are due to a
pH-dependent conformational change of the protein, then this
change should be revealed by £uorescence and CD spectros-
copies. Both techniques were used in this study to analyze the
secondary structure of AnxVI and the potential changes of
environment of the aromatic Trp residues of the protein.
To test the latter presumption, the £uorescence of two re-
porter Trp residues in the AnxVI molecule, Trp192 and Trp343,
was measured as a function of pH. In Fig. 3A, three typical
£uorescence emission spectra are shown, revealing that a drop
in pH of the assay medium is associated with the decrease of
Trp £uorescence at pH 3.0 (by 45% in comparison to pH 8.0)
and a shift of the maximum of the AnxVI emission spectrum
to longer wavelengths, from Vmax = 336 nm at pH 8.0 to 340
nm at pH 4.6 and 346 nm at pH 3.0. Moreover, AnxVI spec-
tra at various pH values relate the magnitude of the red shift
of emission spectrum to decreasing pH values (Fig. 3B). This
suggests that the tertiary structure of AnxVI at various pH
values varies from each other by the exposure of Trp residues
to the surrounding milieu. In addition, while the intrinsic £uo-
rescence maximum shifts from Vem = 336 nm to 346 nm upon
acidi¢cation of the assay medium and the absence of TNS
(Fig. 3B), such a shift is not observed in the presence of
hydrophobic probe (Vmax = 336 nm). This observation could
Fig. 1. TNS binding to porcine AnxVI. A: The protein (1 WM) was
dissolved in either citric bu¡er (pH 3.0^6.2) or Tris^HCl bu¡er (pH
7.4^8.3). The TNS emission spectra (Vex = 345 nm) in the presence
of AnxVI were determined at pH 7.4 (solid line), 6.2 (dash line), 5.5
(dot line) and 4.6 (dot^dash line). The spectrum of 5 WM TNS with-
out AnxVI is also shown (short dash^dot line). B: Typical £uores-
cence emission spectra of AnxVI (1 WM) in the presence of various
TNS concentrations (from 0 to 30 WM) demonstrate FRET between
donor (AnxVI Trp residues, excited at Vex = 295 nm) and acceptor
(TNS, emission peak at Vem = 427 nm) at pH 4.6.
Fig. 2. pH-dependence of FRET e⁄ciency. FRET was determined
in the presence of 1 WM AnxVI and TNS concentrations varying
from 0 to 30 WM. The pH values of the assay media were as fol-
lows: pH 8.0 (¢lled squares), pH 6.2 (open circles), pH 5.0 (¢lled
circles), pH 4.0 (open triangles) and pH 3.0 (¢lled triangles). The
FRET e⁄ciency was calculated from the spectra determined as in
Fig. 1B, using the equation given in Section 2. The mean val-
ues þ S.D. from three experiments are shown.
FEBS 24831 1-5-01
M. Golczak et al./FEBS Letters 496 (2001) 49^5450
be due to a shielding e¡ect, however, it is also valid that
FRET, upon binding of TNS to AnxVI, occurred in the vi-
cinity of AnxVI Trp residues and that this may prevent a red
shift of Trp £uorescence upon acidi¢cation of the assay me-
dium.
Due to the tendency of various proteins to aggregate at
acidic pH, the pH-dependent aggregation pro¢le of AnxVI
was determined using light scattering at 90‡ of a protein so-
lution as a function of pH (Fig. 4A). The determinations
revealed that, in the pH range from 4.8 to 5.8 (including the
pI value of AnxVI), AnxVI in solution tends to aggregate,
although, the aggregation is reversible by raising the pH
above 6.0 or by lowering it below 4.0. The absence of signi¢-
cant light scattering at a pH below 4.0 does not preclude the
possibility of formation of AnxVI oligomers, due to the ten-
dency of Anxs to interact with each other on the membrane
surface [21^24].
To follow conformational transitions of the protein induced
by acidic pH, we have determined the far-UV CD spectra of
AnxVI as a function of pH. Except pH values ranging from
pH 4.8 to pH 5.9, it was possible to measure the CD spectra
of AnxVI at pHs below 4.0 and above 6.0 (Fig. 4B). These
spectra allowed us to distinguish two secondary structure
states of AnxVI, as shown in Fig. 4C,D. These states di¡er
from each other by the values of ellipticity (expressed in
mdeg) of protein determined at V equal to 209 and 222 nm,
i.e. the determinants of K-helix structures of protein (Fig. 4C).
In parallel, we observed that lowering the pH of the assay
medium results not only in a drop of K-helix content (both
regular and distorted K-helices [25]) of AnxVI from 88.2% at
pH 7.4 to 50.7% at pH 3.0 (Table 1) but also in the formation
of new L-structures; their content changed from 1.2% at pH
7.4 to 23.2% at pH 3.0 (Table 1, Fig. 4D). This was accom-
panied by a reduction of the number of segments within the
Anx molecule, from 8.2 segments per 100 residues at pH 7.4
to 4.8 segments per 100 residues at pH 3.0. The number of
segments calculated on the basis of CD determinations at pH
7.4 is 29% larger than the number of segments obtained from
analysis of crystal structure of AnxVI (5.8 per 100 residues)
[6]. Surprisingly, the average length of these segments did not
Fig. 3. The pH-dependent blue shift of the £uorescence emission
maximum of the Trp residues of AnxVI. A: The emission spectra
(Vex = 295 nm) were measured at pH 3.0 (dashed line), pH 4.6 (dot-
ted line) and pH 8.0 (solid line) at 25‡C in 10 mM bu¡ers, supple-
mented with 50 mM NaCl and 0.1 mM EGTA. The protein concen-
tration was 0.2 WM. B: The maxima of £uorescence emission
spectra of AnxVI in the pH range shown in the abscissa to the ¢g-
ure were determined under the same conditions as described in (A)
in triplicate. The mean values of Vmax þ S.D. of £uorescence emis-
sion spectrum are plotted. The data resolution was 1 nm.
Fig. 4. The e¡ect of pH on the aggregation of AnxVI in solution
and its secondary structure. A: The ability of AnxVI solutions to
scatter UV light at 25‡C was determined under conditions described
in Section 2. The light wavelength was ¢xed at 400 nm. The AnxVI
concentration was 0.2 mg/ml, i.e. 2.9 WM. The mean values from
three determinations þ S.D. are shown. B: Typical far-UV CD spec-
tra of AnxVI at di¡erent pH values were measured at 25‡C. The as-
say medium (of total volume 0.5 ml) contained 0.1 mg of AnxVI in
a bu¡er of pH 8.0 (solid line), pH 6.2 (dot^dash line), pH 4.0 (dot-
ted line) or pH 3.0 (dash line). C: Values of CD signals of AnxVI
at V 222 nm (open circles) and 209 nm (¢lled circles), corresponding
to signals characteristic for K-helix structures, are plotted. D: The
L-structure content of AnxVI was calculated from the spectra de-
picted in (B) with the aid of Contin software. The pH values ranged
from 3.0 to 8.0. The mean values þ S.D. from at least three determi-
nations are depicted in (C) and (D). The hatched area represents
the pH value range from 4.8 to 5.9 where we were unable to accu-
rately record the CD spectra of AnxVI due to protein aggregation.
Table 1
The e¡ect of pH on a secondary structure of AnxVI
pH Regular K-helix Distorted K-helix Regular L-strands Distorted L-strands Turns Unordered structures
3.0 31.2 þ 1.2 19.5 þ 0.9 12.2 þ 1.5 11.0 þ 0.9 12.3 þ 2.4 13.9 þ 1.7
4.2 32.2 þ 0.8 17.7 þ 0.8 12.0 þ 1.2 10.3 þ 1.2 12.5 þ 2.6 13.2 þ 1.6
6.2 42.8 þ 4.1 26.2 þ 4.2 1.0 þ 1.0 6.8 þ 3.2 4.9 þ 1.1 8.3 þ 1.0
7.4 67.1 þ 4.5 21.1 þ 3.4 0.1 þ 0.1 1.1 þ 0.6 2.6 þ 0.7 7.8 þ 0.9
Calculations are based on the CD spectra measured under the conditions detailed in the legend to Fig. 4B. The mean values þ S.D. from at
least three determinations are shown and were calculated with the aid of Contin software. Distorted structures, according to the de¢nition given
in the software description, are related to the structures that are characterized by deviations from ideal conformational angles, leading to distor-
tions in the secondary structure such as bends, twists, end frying, etc. [25].
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change much as a function of pH: from 13.9 residues per
segment at pH 7.4 to 11.2 residues per segment at pH 3.0.
These results, taken together, indicate that a signi¢cant sec-
ondary structure of AnxVI persists even at acidic pH, and
acidi¢cation is not accompanied by denaturation of protein,
as also examined previously with the use of Fourier trans-
formed infrared spectroscopy [9].
4. Discussion
This report provides evidence of a Ca2-independent in-
crease in the level of exposed hydrophobic surface of AnxVI
at low pH. In this respect, AnxVI is similar to other members
of the Anx family of proteins (AnxV and AnxXII) [26^28].
The changes in hydrophobic surface of AnxVI accompany the
Ca2-independent formation of ion channels by AnxVI at
acidic pH (with a single channel conductance of 23 pS [9])
and a Ca2-independent conformational change resulting in
the conversion of K-helical (338.3% at pH 4.2, Table 1) to L-
sheet structure (+21.1% at pH 4.2, Table 1). In addition, far-
UV CD data show that the number of K-helical segments in
AnxVI is lowered by pH and the average length of the re-
maining K-helical segments does not change. Together, the
described and reported properties of AnxVI appear connected
to the membrane-bound Ca2-independent forms of the pro-
tein that can only be removed from the membrane bilayer by
detergent solubilization [10^13]. The ability of AnxVI to bind
Ca2 declines with lower pH, in accordance with all the Ca2-
independent properties of AnxVI [9]. Any proposed mecha-
nism describing the low pH, Ca2-independent behavior of
AnxVI must take into account these properties and the cellu-
lar localization, known links to disease and potental function-
al pathways of AnxVI. Knowledge acquired from unrelated
proteins with similar properties may provide further clues.
AnxVI associates speci¢cally with membranes of low pH
compartments (i.e. late endosomes and synaptosomes) in a
number of cell types, indicating a role of AnxVI at late stages
of the endocytic pathway [29^31]. It has been recently shown
that the membrane association of endosomal coat proteins
(COPs), involved in membrane transport in the endocytic
pathway, depends on an acidic endosomal pH. It was found
that membrane recruitment of endosomal COPs depends on a
small cytosolic GTP-binding protein, ARF1. The membrane
association of ARF1 is sensitive to the endosomal pH, per-
haps through a binding to a transmembrane protein that
changes its conformation on the cytosolic side of the endo-
some membrane upon acidi¢cation of the endosome lumen
[32]. Therefore, ARF1 acts as the cytosolic component of a
transmembrane pH-sensing mechanism [32]. It can be specu-
lated that AnxVI also reveals transmembrane pH-sensing
properties that may explain the preferential binding of AnxVI
to late endosomes characterized by an acidic interior. How-
ever, in contrast to ARF1, AnxVI probably does not require
additional endosomal protein for binding to endosome mem-
brane, being itself a pH-dependent protein. If so, it is possible
that under physiological conditions AnxVI may sense lower
pH values than in the cytosol.
How and where do such areas of low pH arise inside the
cell? A possible explanation can be provided by the observa-
tion made by Van der Goot et al. [33] who studied the inter-
action of colicin A with membranes made of anionic phos-
pholipids. They found the local pH value near the surface of
such membranes is lower than in the cytoplasm by 1.6 pH
units [33]. Taking into account that AnxVI preferentially in-
teracts with membranes enriched with acidic phospholipids
[34], one may consider a similar sensitivity of AnxVI for a
lower interfacial pH as that described for colicin A. It must be
stressed, however, that the half-maximal association of AnxVI
with lipid bilayers occurs in vitro at pH 5.3 [9], i.e. in a pH
range outside cytosolic pH variations. On the other hand,
membrane integration of AnxVI may occur at localized areas
of higher H concentrations connected with membrane lipid
microdomains consisting of acidic phospholipids and/or their
protein components.
The low pH-sensitivity of AnxVI could be of particular
importance under pathological or stressful conditions. For
example, the pH inside muscle ¢bers can decline from pH
7.1 to pH 6.5 due to skeletal muscle fatigue [35]. This change
a¡ects the function of Ca2-transport systems, as observed for
the rabbit skeletal muscle ryanodine receptor that was in vitro
inhibited with a half-inhibitory cytoplasmic pH of 6.5 [36].
Intracellular acidosis is also a recognised result of ischemia.
In one experimental system of ischemia, the result was de-
creased insulin signalling through the in£uence of tyrosine
phosphorylation of the insulin receptor and changes in the
activity of various kinases [37]. Anxs were not directly impli-
cated in this study. However, Anxs do participate in insulin
secretion through various mechanisms and may also become
targets in ischemia. For example, anti-AnxXI antibodies were
found to inhibit insulin secretion from pancreatic L-cells [38]
and the heterozygous anx7 (+/3) mouse phenotype was asso-
ciated with a substantial defect in insulin secretion [39]. Anx-
VI is also involved in other secretion pathways, for example,
AnxVI was found secreted from hepatocytes into bile [40].
Ischemia also accompanies programmed cell death (apopto-
sis) and multidrug resistance of various cell lines that are
characterized by changes in intracellular pH gradients that
a¡ect the accumulation, secretion and endocytosis of anti-can-
cer drugs [41]. It was shown that apoptosis of murine thymo-
cytes, induced by extracellular ATP, is accompanied with a
rapid intracellular acidi¢cation (by 0.3 pH units) [42], and
apoptosis of rat superior cervical ganglion cells in vitro, in-
duced by Na overload, results in a pH drop to 6.5 [43].
These observations, if AnxVI would be involved, imply the
transformation of part of AnxVI from a cytosolic to mem-
brane integral protein.
The question remains what is the molecular mechanism for
extrusion of AnxVI into the membrane hydrophobic core.
Changes of pH evoked aggregation of AnxV and folding of
its domain III, which contains the Trp187 residue that plays a
role in Anx-membrane binding [44,45]. For AnxV and hydra
AnxXII, pH-induced changes in protein hydrophobicity
[26,27] were accompanied by the insertion of these proteins
into lipid bilayers and the formation of ion channels [27,46].
In addition, for hydra AnxXII, acidic pH-induced oligomeri-
zation was found of importance for its channel activity [28,46]
while for AnxV, playing a role in the calci¢cation of the
matrix, changes in protein hydrophobicity were indispensable
for pH-induced membrane insertion of the protein [26]. In
contrast to the pH-induced changes observed for AnxV
[17,26,43,47], AnxVI undergoes larger conformational changes
and the transition of the native to low pH-induced state is
already observed at pH 6.2.
The structural transition involving the rearrangement from
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K-helix-rich to L-structure-rich state, as described in this re-
port for AnxVI, was also observed for a cytolytic exotoxin
from Clostridium perfringens, perfringolysin O. This toxin
binds to cholesterol-rich membranes and self-associates to
form aqueous pores. The cholesterol-dependent conversion
of the toxin to a membrane-bound oligomeric form involves
the formation of a large prepore complex and transition in
which at least four K-helices unfold to form a membrane-
spanning amphipathic L-sheet [48^50]. A similar pH-depen-
dent conversion was described for cellular prion protein,
PrPC. The conversion from monomeric PrPC to an infectious
agent of transmissible spongiform encephalitis, e.g. oligomeric
prion protein, was found to be characterized by a decrease in
K-helical structure and increase in L-sheet content, and the
formation of amyloid [51]. The stable intermediate of prion
protein upon acidi¢cation was rich in L-sheet structures [52].
It is possible that the formation of new L-structures in the
AnxVI molecule is responsible for membrane insertion of
the Anx. However, in the case of the transmembrane form
of recombinant hydra AnxXII, detected by site-directed spin
labeling, it was found that upon insertion at the membrane a
continuous transmembrane K-helix is formed from a helix^
loop^helix motif (within the Anx fold). It was proposed that
the corresponding long helices come together to form an
aqueous pore [45]. No evidence for such a transition was
observed from the far-UV CD spectra of AnxVI. These spec-
tra were determined, however, in solution. Work is in progress
in our laboratory to further characterize the mechanism of
pH-induced conformational transitions within the AnxVI
molecule upon membrane insertion. We will also search for
target molecules of AnxVI and physiological processes under
which pH-induced changes in AnxVI properties may play a
regulatory role.
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